#NLAAD celebrates 20 years of Latino AIDS education on Sunday, October 15. This year’s theme focuses on various ways to prevent HIV.

Armando Herrera sold adulterated and misbranded HIV drugs through companies in six states. He faces a maximum of five years in prison.

When given a choice, most women chose injectable cabotegravir over daily prevention pills.

Research on the links between tenofovir and other antiretrovirals, SARS-CoV-2 infection and COVID severity has produced mixed results.

There are now three FDA-approved PrEP medications in the United States—two are pills, and one is a shot.

Findings suggest that daily oral PrEP or long-acting injectables might be better options for young men who have spontaneous sex.

Internal documents show Gilead held off on developing new therapies, such as Descovy, a potentially less toxic version of Truvada.

Eleven years ago, Truvada became the first medication approved for HIV prevention. Today, disparities in PrEP coverage still exist.

The $3.6 billion antitrust court case cleared Gilead Sciences and Teva of delaying the release of generic Truvada and other HIV meds.